A Study of MR001 Combined With Chemotherapy in Patients With Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) After First-line Therapy
Clinical trial NCT07235202 · RECRUITING
Trial details
- NCT number
- NCT07235202
- Sponsor
- Shenzhen Majory Biotechnology Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-24
- Primary completion
- 2028-06-22
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.